3U01AG006781-31S1 |
2020 |
$3102857 |
Alzheimer's Disease Patient Registry (ADPR/ACT) |
KAISER FOUNDATION RESEARCH INSTITUTE |
5U01AG006781-31 |
2019 |
$3102858 |
Alzheimer's Disease Patient Registry (ADPR/ACT) |
KAISER FOUNDATION RESEARCH INSTITUTE |
7U01AG006781-30 |
2018 |
$2540437 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
KAISER FOUNDATION RESEARCH INSTITUTE |
3U01AG006781-30S1 |
2018 |
$282915 |
Alzheimers Disease Patient Registry (ADPR/ACT) |
KAISER FOUNDATION RESEARCH INSTITUTE |
3U01AG006781-30S2 |
2018 |
$376464 |
Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicity |
KAISER FOUNDATION RESEARCH INSTITUTE |
5U01AG006781-29 |
2017 |
$2574134 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
5U01AG006781-28 |
2016 |
$2641512 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
3U01AG006781-28S1 |
2016 |
$155477 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
2U01AG006781-27A1 |
2015 |
$2755015 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
3U01AG006781-26S1 |
2014 |
$652628 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
5U01AG006781-26 |
2013 |
$2165499 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
3U01AG006781-24S1A1 |
2012 |
$128289 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
5U01AG006781-25 |
2012 |
$2393397 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
5U01AG006781-24 |
2011 |
$2278810 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
5U01AG006781-23 |
2010 |
$2376521 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |
5U01AG006781-21 |
2008 |
$1079470 |
ALZHEIMER'S DISEASE PATIENT REGISTRY (ADPR) |
GROUP HEALTH COOPERATIVE |